{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:32:37Z","timestamp":1784190757399,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Asia"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jacasi.2026.03.019","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T01:04:32Z","timestamp":1780016672000},"page":"1081-1091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Natto Red Yeast Rice Supplement Regulates Lipid Profiles"],"prefix":"10.1016","volume":"6","author":[{"given":"Fangchao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengchao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1961-899X","authenticated-orcid":false,"given":"Yingxian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4088-2338","authenticated-orcid":false,"given":"Xiangfeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfeng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacasi.2026.03.019_bib1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41569-021-00541-4","article-title":"Global epidemiology of dyslipidaemias","volume":"18","author":"Pirillo","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacasi.2026.03.019_bib2","series-title":"confronting the world's number one killer","year":"2023"},{"key":"10.1016\/j.jacasi.2026.03.019_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155999","article-title":"Global burden of metabolic diseases, 1990-2021","volume":"160","author":"Zhang","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.jacasi.2026.03.019_bib4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ehjqcco\/qcae090","article-title":"Burden of cardiovascular disease attributable to metabolic risks in 204 countries and territories from 1990 to 2021","volume":"11","author":"Chen","year":"2025","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jacasi.2026.03.019_bib5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.26599\/1671-5411.2023.09.008","article-title":"2023 China guidelines for lipid management","volume":"20","author":"Li","year":"2023","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.jacasi.2026.03.019_bib6","first-page":"681","article-title":"[Status of dyslipidemia among adults aged 35 years and above in China]","volume":"34","year":"2019","journal-title":"Zhongguo Xun Huan Za Zhi (Chin Circ J)"},{"key":"10.1016\/j.jacasi.2026.03.019_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2026.03.019_bib8","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacasi.2026.03.019_bib9","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurheartj\/eht055","article-title":"HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin\/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment","volume":"34","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2026.03.019_bib10","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/eurheartj\/ehaa574","article-title":"Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom","volume":"41","author":"Hopewell","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2026.03.019_bib11","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1136\/ejhpharm-2022-003333","article-title":"Adverse drug reactions of statin therapy in China from 1989 to 2019: a national database analysis","volume":"30","author":"Tsui","year":"2023","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.jacasi.2026.03.019_bib12","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41569-018-0098-5","article-title":"Safety and efficacy of statin therapy","volume":"15","author":"Adhyaru","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacasi.2026.03.019_bib13","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3390\/molecules24101944","article-title":"Quality and authenticity control of functional red yeast rice-a review","volume":"24","author":"Song","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jacasi.2026.03.019_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2015.04.004","article-title":"Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis","volume":"240","author":"Gerards","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacasi.2026.03.019_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/1177271918785130","article-title":"Nattokinase: a promising alternative in prevention and treatment of cardiovascular diseases","volume":"13","author":"Chen","year":"2018","journal-title":"Biomark Insights"},{"key":"10.1016\/j.jacasi.2026.03.019_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1076420","article-title":"Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: a clinical study with 1,062 participants","volume":"9","author":"Chen","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacasi.2026.03.019_bib17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1142\/S0192415X19500150","article-title":"A randomized clinical efficacy trial of red yeast rice (monascus pilosus) against hyperlipidemia","volume":"47","author":"Wang","year":"2019","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.jacasi.2026.03.019_bib18","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.3390\/nu15194239","article-title":"The effect of nattokinase-monascus supplements on dyslipidemia: a four-month randomized, double-blind, placebo-controlled clinical trial","volume":"15","author":"Liu","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.jacasi.2026.03.019_bib19","first-page":"310","article-title":"Combined nattokinase with red yeast rice but not nattokinase alone has potent effects on blood lipids in human subjects with hyperlipidemia","volume":"18","author":"Yang","year":"2009","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/j.jacasi.2026.03.019_bib20","article-title":"Lipid-lowering, antihypertensive, and antithrombotic effects of nattokinase combined with red yeast rice in patients with stable coronary artery disease: a randomized, double-blinded, placebo-controlled trial","volume":"11","author":"Liu","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.jacasi.2026.03.019_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2022.10.013","article-title":"Comparative effects of low-dose rosuvastatin, placebo, and dietary supplements on lipids and inflammatory biomarkers","volume":"81","author":"Laffin","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.03.019_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s40795-022-00639-z","article-title":"Evaluation the effects of red yeast rice in combination with statin on lipid profile and inflammatory indices; a randomized clinical trial","volume":"8","author":"Tavan","year":"2022","journal-title":"BMC Nutr"},{"key":"10.1016\/j.jacasi.2026.03.019_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.amjcard.2018.09.041","article-title":"Usefulness of low-dose statin plus ezetimibe and\/or nutraceuticals in patients with coronary artery disease intolerant to high-dose statin treatment","volume":"123","author":"Marazzi","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacasi.2026.03.019_bib24","first-page":"122","article-title":"Evaluation of natto red yeast rice on regulating blood lipid (ENTRY) study: a multicenter, double-placebo, double-blinded, randomized controlled trial in Chinese adults","volume":"11","author":"Chen","year":"2025","journal-title":"Chronic Dis Transl Med"},{"key":"10.1016\/j.jacasi.2026.03.019_bib25","first-page":"1","article-title":"2016 Chinese guidelines for the management of dyslipidemia in adults","volume":"15","year":"2018","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.jacasi.2026.03.019_bib26","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/CIRCULATIONAHA.116.022367","article-title":"Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-Par project (prediction for ASCVD risk in China)","volume":"134","author":"Yang","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.03.019_bib27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jamaneurol.2024.1433","article-title":"Immediate- or delayed-intensive statin in acute cerebral ischemia: the inspires randomized clinical trial","volume":"81","author":"Gao","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jacasi.2026.03.019_bib28","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacasi.2026.03.019_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c2697","article-title":"Modified intention to treat reporting in randomised controlled trials: systematic review","volume":"340","author":"Abraha","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jacasi.2026.03.019_bib30","doi-asserted-by":"crossref","first-page":"922","DOI":"10.7326\/M22-2974","article-title":"Acupuncture and doxylamine-pyridoxine for nausea and vomiting in pregnancy: a randomized, controlled, 2 x 2 factorial trial","volume":"176","author":"Wu","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacasi.2026.03.019_bib31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF02924688","article-title":"Multiple imputation for nonresponse in surveys","volume":"31","author":"Toutenburg","year":"1990","journal-title":"Stat Pap (Berl)"},{"key":"10.1016\/j.jacasi.2026.03.019_bib32","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3390\/nu15040973","article-title":"Supplementation with natto and red yeast rice alters gene expressions in cholesterol metabolism pathways in ApoE(-\/-) mice with concurrent changes in gut microbiota","volume":"15","author":"Zhou","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.jacasi.2026.03.019_bib33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"290","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacasi.2026.03.019_bib34","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.03.019_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1398934","article-title":"Effects of the combination of red yeast rice-containing commercial Chinese polyherbal preparation with statins for dyslipidemia: a systematic review and meta-analysis","volume":"15","author":"Shi","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacasi.2026.03.019_bib36","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3390\/nu17111784","article-title":"Research progress of nattokinase in reducing blood lipid","volume":"17","author":"Wei","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.jacasi.2026.03.019_bib37","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.phymed.2015.10.011","article-title":"Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: the available clinical data","volume":"23","author":"Cicero","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jacasi.2026.03.019_bib38","first-page":"1831","article-title":"The effects of red yeast rice dietary supplement on blood pressure, lipid profile, and C-reactive protein in hypertension: a systematic review","volume":"57","author":"Xiong","year":"2017","journal-title":"Crit Rev Food Sci Nutr"}],"container-title":["JACC: Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277237472600178X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277237472600178X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T20:38:21Z","timestamp":1784147901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277237472600178X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S277237472600178X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacasi.2026.03.019","relation":{},"ISSN":["2772-3747"],"issn-type":[{"value":"2772-3747","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natto Red Yeast Rice Supplement Regulates Lipid Profiles","name":"articletitle","label":"Article Title"},{"value":"JACC: Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacasi.2026.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}